Viteva  Home logo
Supplement Safety

 Untitled 1
Red Yeast Rice Research

Cholesterol-lowering effects of a proprietary Chinese red-yeast-rice dietary supplement.

Xuezhikang decreases serum lipoprotein(a) and C-reactive protein concentrations in patients with coronary heart disease.

Red yeast rice: a new hypolipidemic drug.

Plasma clearance of lovastatin versus chinese red yeast rice in healthy volunteers.

Potential protective effect of long-term therapy with Xuezhikang on left ventricular diastolic function in patients with essential hypertension.

Effect of Xuezhikang, an extract from red yeast Chinese rice, on coronary events in a Chinese population with previous myocardial infarction.


 Untitled 1
   Home    Terms of Use    Privacy
Home    Research    Terms of Use    Privacy Policy    Advertise    Newsletter    About Us    Contact Us
Copyright ©2009 Viteva